Medical Data Vision Co., Ltd. (3902.T)
JPY 378.0
(-1.31%)
JPY 378.0
(-1.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.61 Billion | 910.79 Million | 1.08 Billion | 964.36 Million | 1.2 Billion | 120.2 Million |
| Net Income | 979.12 Million | 1.42 Billion | 1.59 Billion | 1.07 Billion | 657.89 Million | 314.98 Million |
| Depreciation & Amortization | 102.02 Million | 149.99 Million | 135.55 Million | 158.79 Million | 180.86 Million | 169.91 Million |
| Deferred income taxes | - | - | -470.82 Million | -153.27 Million | -142.37 Million | -124.63 Million |
| Stock-based compensation | - | - | 1.87 Million | 8.35 Million | 7.66 Million | 5.11 Million |
| Change in working capital | 26 Thousand | -305.19 Million | -181.33 Million | -78.08 Million | 456.74 Million | -123.42 Million |
| Other non-cash items | 535.14 Million | -360.59 Million | 5.45 Million | -48.02 Million | 41.43 Million | -121.75 Million |
| Investing Cash Flow | -437.83 Million | -868.75 Million | -26.93 Million | -142.58 Million | -31.26 Million | -271.83 Million |
| Investments in PPE | -30.2 Million | -53.24 Million | -24.04 Million | -27.05 Million | -81.28 Million | -118.7 Million |
| Acquisitions | - | -467.09 Million | - | -108.02 Million | -47.14 Million | 29.9 Million |
| Investment purchases | -393.74 Million | -412.4 Million | -20.41 Million | - | -4.17 Million | -135.5 Million |
| Sales/Maturities of investments | - | 80.41 Million | 18.01 Million | - | 100.04 Million | - |
| Other Investing Activities | -13.88 Million | -16.43 Million | -491 Thousand | -7.5 Million | 1.29 Million | -17.63 Million |
| Financing Cash Flow | -225.26 Million | -979.35 Million | -1.03 Billion | -589.64 Million | 199.34 Million | 28.36 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -228.82 Million | -217.68 Million | -141.52 Million | - | - | - |
| Common Stock Repurchased | - | -871.87 Million | -889.07 Million | -589.64 Million | -55 Thousand | -359 Thousand |
| Common Stock Issuance | 3.56 Million | - | - | - | - | - |
| Other Financing Activities | 3.56 Million | 110.2 Million | -1000.00 | -589 Million | 199.4 Million | 28.72 Million |
| Accounts receivables | -167.87 Million | -282.92 Million | -190.89 Million | -95.48 Million | 201.67 Million | -154.76 Million |
| Accounts payables | 47.43 Million | -4.11 Million | 21.25 Million | -207 Thousand | 1.85 Million | -12.29 Million |
| Inventory | 10.76 Million | -820 Thousand | 24.49 Million | 1.06 Million | 481 Thousand | 11.76 Million |
| Other working capital | 109.7 Million | -17.33 Million | -36.19 Million | 16.53 Million | 252.73 Million | -135.18 Million |
| Cash at beginning of period | 2.26 Billion | 3.2 Billion | 3.17 Billion | 2.94 Billion | 1.57 Billion | 1.69 Billion |
| Cash at end of period | 3.21 Billion | 2.26 Billion | 3.2 Billion | 3.17 Billion | 2.94 Billion | 1.57 Billion |
| Capital Expenditure | -30.2 Million | -53.24 Million | -24.04 Million | -27.05 Million | -81.28 Million | -118.7 Million |
| Effect of forex changes on cash | -1000.00 | -1000.00 | -1000.00 | -1000.00 | 1000.00 | - |
| Net cash flow / Change in cash | 953.21 Million | -937.31 Million | 25.08 Million | 232.13 Million | 1.37 Billion | -123.26 Million |
| Free Cash Flow | 1.58 Billion | 857.55 Million | 1.05 Billion | 937.31 Million | 1.12 Billion | 1.49 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15 Million | 320 Million | 979.12 Million | 214 Million | 170 Million | 275 Million |
| Depreciation & Amortization | - | 26.43 Million | 102.02 Million | 26.14 Million | 25.2 Million | 24.23 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 26 Thousand | - | - | - |
| Other non-cash items | 15 Million | -320 Million | 535.14 Million | -214 Million | -170 Million | -275 Million |
| Investing Cash Flow | - | - | -437.83 Million | - | - | - |
| Investments in PPE | - | - | -30.2 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | -393.74 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -13.88 Million | - | - | - |
| Financing Cash Flow | - | - | -225.26 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -228.82 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 3.56 Million | - | - | - |
| Other Financing Activities | - | - | 3.56 Million | - | - | - |
| Accounts receivables | - | - | -167.87 Million | - | - | - |
| Accounts payables | - | - | 47.43 Million | - | - | - |
| Inventory | - | - | 10.76 Million | - | - | - |
| Other working capital | - | - | 109.7 Million | - | - | - |
| Cash at beginning of period | - | 2.86 Billion | 2.26 Billion | 3 Billion | 2.48 Billion | 2.26 Billion |
| Cash at end of period | - | 3.21 Billion | 3.21 Billion | 2.86 Billion | 3 Billion | 2.48 Billion |
| Capital Expenditure | - | - | -30.2 Million | - | - | - |
| Effect of forex changes on cash | - | - | -1000.00 | - | - | - |
| Net cash flow / Change in cash | - | 355.63 Million | 953.21 Million | -144.65 Million | 518.18 Million | 224.05 Million |
| Free Cash Flow | - | 52.87 Million | 1.58 Billion | 52.29 Million | 50.41 Million | 48.46 Million |
SEAT
1585
BPMC
009420
002298
RBL